We want to demonstrate our commitment to your privacy. In support of the changes to the EU data protection law, we�ve updated our privacy notice effective May 25, 2018.

Virtual Incision is reimagining robotic support for minimally invasive (MIS) procedures with simple innovations offering mobility, flexibility, and accessibility to provide MIS options to more patients. The company is developing the MIRA® (Miniaturized In vivo Robotic Assistant) Platform, a first-of-its-kind miniaturized surgical robotic support device, focusing first on colon resection, with follow-on specialty robots for additional potential applications.

Website: www.virtualincision.com

Shane Farritor, CTO, is the David and Nancy Lederer Professor of Mechanical Engineering at the University of Nebraska-Lincoln. He is co-founded Virtual Incision Corporation that is developing miniature robotic devices that are placed inside the body during laparoscopic surgery. Dr. Farritor holds more than 150 patents and is a fellow of the National Academy of Inventors.

John Murphy, CEO, is a global medical technology and health sciences executive who has held leadership roles in large public companies, middle-market private equity businesses, and venture capital environments over the past 20 years. He holds graduate and undergraduate degrees in computer science and a MBA in international finance.

Dr. Dmitry Oleynikov, Cofounder and Chief Medical Officer, is an active investigator and researcher in the College of Medicine with over 200 peer-reviewed articles, and 25 patents in the area of surgical robotics and surgical outcomes research. The Society of American Gastrointestinal and Endoscopic Surgeons has recognized him for his achievements with an award in Excellence in Leadership and currently serves as Chair of Surgery at RWJ Monmouth Medical Center and Professor of Surgery at RWJ Rutgers University Medical School.